Increasing Vaccine Uptake Among Veterans at the Atlanta VA Health Care System
1 other identifier
interventional
67,000
1 country
1
Brief Summary
The Office of Evaluation Sciences is collaborating with Emory University and the Atlanta VA Health Care System to increase adult immunizations uptake among veterans. The intervention targets patients of primary care providers (physicians, physician assistants and nurse practitioners) through a modification of the existing reminders in the VA electronic health record system. The team will evaluate the intervention using a randomized controlled trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 15, 2018
CompletedFirst Submitted
Initial submission to the registry
April 25, 2019
CompletedFirst Posted
Study publicly available on registry
May 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2019
CompletedJanuary 10, 2020
January 1, 2020
8 months
April 25, 2019
January 7, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Percent of patients receiving one of more vaccines of interest when due for these vaccines
Percent of patients receiving of one or more of the influenza, pneumococcal (PCV13 or PPSV23) or Tdap/Td vaccines during the observation period, conditional on the patient being due for at least one of these vaccines at any appointment during the observation period
6 months
Percent of patients receiving the influenza vaccine when due for the vaccine
Percent of patients receiving the influenza vaccine during the observation period, conditional on the patient being due for the influenza vaccine at any appointment during the observation period
6 months
Secondary Outcomes (2)
Percent of patients receiving Tdap/Td or pneumococcal vaccines when due
6 months
Cost per additional individual vaccinated
6 months
Study Arms (2)
Control
NO INTERVENTIONProviders assigned to the control group will receive unmodified vaccine reminders (as they already appear in the VA EHR system). Separate reminders will appear for the different vaccines of interest.
Treatment
EXPERIMENTALProviders in the treatment group will receive modified clinical reminders for the vaccines of interest. Reminders for the different vaccines of interest will be bundled into a single reminder, and other changes made to streamline the design and reduce provider burden. Other changes include an immunization dashboard that relays a patient's vaccination status and talking points for providers to use in their dialogues with patients.
Interventions
Clinical reminders for the vaccines of interest will be bundled into a single reminder, and other changes made to streamline the design and reduce provider burden. Other changes include an immunization dashboard that relays a patient's vaccination status and talking points for providers to use in their dialogues with patients.
Eligibility Criteria
You may qualify if:
- All patients must have appointments with active primary care providers (physicians, physician assistants and nurse practitioners) in the Atlanta VA Health Care System
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Atlanta VA Medical Centerlead
- General Services Administration (GSA)collaborator
- Emory Universitycollaborator
Study Sites (1)
Atlanta VA Medical Center
Decatur, Georgia, 30033, United States
Related Publications (1)
Debroy P, Balu R, Burnett R, Johnson RA, Kappes HB, Wallace JM, Marconi VC. A cluster randomized controlled trial of a modified vaccination clinical reminder for primary care providers. Health Psychol. 2023 Mar;42(3):195-204. doi: 10.1037/hea0001218. Epub 2022 Oct 13.
PMID: 36227309DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pompa Debroy, MS
Office of Evaluation Sciences, U.S. General Services Administration
- PRINCIPAL INVESTIGATOR
Russ Burnett, PhD
Office of Evaluation Sciences, U.S. General Services Administration
- PRINCIPAL INVESTIGATOR
Saad Omer, MBBS, MPH, PhD
Emory University
- PRINCIPAL INVESTIGATOR
Joseph M Wallace
Atlanta VA Health Care System
- PRINCIPAL INVESTIGATOR
Vincent Marconi, MD
Atlanta VA Health Care System, Emory University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Infectious Diseases Research
Study Record Dates
First Submitted
April 25, 2019
First Posted
May 15, 2019
Study Start
October 15, 2018
Primary Completion
May 30, 2019
Study Completion
June 30, 2019
Last Updated
January 10, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share